Relay Therapeutics

Relay Therapeutics Shares Positive Phase 2 Zovegalisib Data

CAMBRIDGE, Mass., May 19, 2026 Relay Therapeutics announced promising initial Phase 2 clinical data for zovegalisib, its investigational mutant-selective...

By cGxPwire Editor
May 20, 2026

Bio-Pharma

Relay Therapeutics Advances Zovegalisib Clinical Data

CAMBRIDGE, Mass., April 2, 2026 Relay Therapeutics, Inc. announced that it will present initial clinical and preclinical data for...

By cGxPwire Editor
April 6, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

Relay Therapeutics

Relay Therapeutics Shares Positive Phase 2 Zovegalisib Data

Relay Therapeutics Advances Zovegalisib Clinical Data